Pacific Edge Ltd
NZX:PEB

Watchlist Manager
Pacific Edge Ltd Logo
Pacific Edge Ltd
NZX:PEB
Watchlist
Price: 0.175 NZD -2.23% Market Closed
Market Cap: 178.9m NZD

P/E
Price to Earnings

-5.2
Current
-3.5
Median
23.5
Industry
Lower than median
Lower than industry value

The Price to Earnings (P/E) ratio shows how much investors are willing to pay for each dollar of a company’s earnings. It’s calculated by dividing the company’s market value by its net income.

P/E
-5.2
=
Market Cap
178.9m NZD
/
Net Income
-34.5m NZD
All Countries
Close
Earnings Growth PEG
NZ
Pacific Edge Ltd
NZX:PEB
Average P/E: 207.6
Negative Multiple: -5.2
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
Negative Multiple: -17 575 047.8 N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 957.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
166.9
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.8
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.5
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
32.1
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -530.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
10%
1.8
AU
CSL Ltd
ASX:CSL
18.2
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 175.1
N/A N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-4
2-Years Forward
P/E
-6.1
3-Years Forward
P/E
-12.7